EligibleTrials

Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction

Recruiting · NCT05479669 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Medical Center Groningen

View the official record on ClinicalTrials.gov →
Heart failure

Interventions studied

24 hour Holter monitoring99mTc-HDP scanCardiac Magnetic Resonance ImagingECGEchocardiography

What this trial is about

Heart failure (HF) with a left ventricular ejection fraction (LVEF) \>0.40 is a large medical problem, for which no drug or device has a recommendation in current HF guidelines. The prevalence of mortality and HF hospitalizations in HF with LVEF \>0.40 is high, but the identification of predictors for increased risk of mortality and HF hospitalizations in this patient category remains difficult. The hypothesis of this study is that the risk of all-cause mortality and HF hospitalizations can be measured by clinical factors, imaging parameters and circulating biomarkers, and that these factors can be used in a risk profile

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.